← Leaderboards
Joe Assouline
Nanomedtrix, Llc
$2,175,120
Attributed
$2,350,240
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,350,240 · 2
By mechanism
R44$2,000,000 · 1
R43$350,240 · 1
Top collaborators
- Yi Luo2 shared
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsPreclinical StudyNanoparticleNovel StrategiesMonitorMalignant NeoplasmsCancer TherapyNanomaterialsIn VitroIntravesicalBladder Transitional Cell CarcinomaLeadLesionMalignant Neoplasm Of Urinary BladderBladder NeoplasmCancer CellCarcinomaBaseDiagnosticCostEnsureEpirubicinBladderScale Up
Grant awards (4)
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles$956,875
R44 · FY2022 · CA · contact PI
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles$1,043,125
R44 · FY2021 · CA · contact PI
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles$55,000
R43 · FY2019 · CA · contact PI
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles$295,240
R43 · FY2018 · CA · contact PI